2-Bromoacridone | 7497-54-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-Bromoacridone
• 英文别名: 2-bromoacridin-9(10H)-one；2-Bromacridon；2-bromo-10H-acridin-9-one
• CAS: 7497-54-3
• 化学式: C₁₃H₈BrNO
• 分子量: 274.117
• InChiKey: DKFRCJAPAAFCQF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-Bromoacridone 在 氯化亚砜 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 1.0h， 生成 2-bromo-9-chloroacridine
  参考文献：
  名称：

  [EN] PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN
  [FR] COMPOSES DE PYRIDIN-4-YLAMINE CONVENANT POUR LE TRAITEMENT DE LA DOULEUR NEUROPATHIQUE

  摘要：

  本发明涉及一种在治疗神经病性疼痛中使用三唑吡啶化合物的方法。本发明还涉及在治疗精神和情绪障碍，如精神分裂症、焦虑、抑郁、躁郁症和恐慌，以及在治疗疼痛、帕金森病、认知功能障碍、癫痫、昼夜节律和睡眠障碍（如倒班引起的睡眠障碍和时差反应）、药物成瘾、药物滥用、药物戒断和其他疾病中使用三唑吡啶化合物的方法。本发明还涉及选择性结合到Ca通道α2δ-1亚基的新型三唑吡啶化合物。

  公开号：

  WO2005051915A1
• 作为产物：
  描述：

  N-(4-溴苯基)邻氨基苯甲酸 在 2,4-双三氟甲基苯硼酸 作用下， 以 neat (no solvent) 为溶剂， 以77 %的产率得到2-Bromoacridone
  参考文献：
  名称：

  环保绿色新型无金属分子内傅克反应以苯硼酸衍生物合成吖啶酮类衍生物

  摘要：

  在此，我们报告了一种新的、简便的、通用的无金属方法，通过 2-(苯氨基) 苯甲酸衍生物和苯硼酸衍生物的分子内羰基化制备各种吖啶酮作为活化剂，用于活化分子内 C C中的羧酸基团通过 Friedel–Crafts 反应形成键。该反应在无溶剂条件下进行，具有广泛的官能团，并能以良好到极好的收率快速获得一系列吖啶酮。

  DOI：

  10.1016/j.tetlet.2023.154532

文献信息

• Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles
  作者：Maryam Mohammadi-Khanaposhtani、Maliheh Safavi、Reyhaneh Sabourian、Mohammad Mahdavi、Mahboobeh Pordeli、Mina Saeedi、Sussan Kabudanian Ardestani、Alireza Foroumadi、Abbas Shafiee、Tahmineh Akbarzadeh

  DOI：10.1007/s11030-015-9616-0

  日期：2015.11

  A new series of 9(10H)-acridinone-1,2,3-triazole derivatives were designed, synthesized and evaluated for their cytotoxic activity against human breast cancer cell lines. The acridone skeleton was prepared through the Ullman condensation of 2-bromobenzoic acid and anilines. Subsequently, it was functionalized with propargyl bromide. Then, a click reaction of the latter compound and in situ prepared 1-(azidomethyl)-4-methoxybenzene derivatives led to the formation of the desired triazole products. Finally, all products were investigated for their capability to cause cytotoxicity against MCF-7, T-47D, and MDA-MB-231 cell lines. Among them, 2-methoxy-10-((1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl)acridin-9(10H)-one 8c exhibited the most potency $$(\hbox IC}_50}\,=}\,11.0\,\pm }\, 4.8\, \upmu \hbox M})$$ against MCF-7 cells, being more potent than etoposide $$(\hbox IC}_50}\,=}\, 12.4\,\pm }\, 4.7 \upmu \hbox M})$$ . Also, apoptosis induced by compound 8c was confirmed via acridine orange/ethidium bromide and Annexin V-FITC/propidium iodide (PI) double staining.

  设计、合成并评价了一系列新的9(10H)-吖啶酮-1,2,3-三氮唑衍生物对人类乳腺癌细胞系的细胞毒活性。通过 Ullman 缩合反应，由2-溴苯甲酸和对胺制备吖啶酮骨架，随后用炔丙基溴进行功能化。然后，后者化合物与原位制备的1-(叠氮甲基)-4-甲氧基苯衍生物进行点击反应，得到所需的三氮唑产物。最后，所有产物被评估其对MCF-7、T-47D和MDA-MB-231细胞系的细胞毒性能力。其中，2-甲氧基-10-((1-(4-甲氧基苄基)-1H-1,2,3-三氮唑-4-基)甲基)吖啶-9(10H)-酮8c对MCF-7细胞表现出最高的活性（IC\(}_50}\)=11.0±4.8μM），比依托泊苷（IC\(}_50}\)=12.4±4.7μM）更有效。此外，通过吖啶橙/溴化乙锭和 Annexin V-FITC/碘化丙啶（PI）双重染色，确认了8c化合物诱导的细胞凋亡。
• Design, Synthesis, Biological Evaluation, and Docking Study of Acetylcholinesterase Inhibitors: New Acridone-1,2,4-oxadiazole-1,2,3-triazole Hybrids
  作者：Maryam Mohammadi-Khanaposhtani、Mohammad Mahdavi、Mina Saeedi、Reyhaneh Sabourian、Maliheh Safavi、Mahnaz Khanavi、Alireza Foroumadi、Abbas Shafiee、Tahmineh Akbarzadeh

  DOI：10.1111/cbdd.12609

  日期：2015.12

  this study, novel acridone‐1,2,4‐oxadiazole‐1,2,3‐triazole hybrids were designed, synthesized, and evaluated for their acetylcholinesterase and butyrylcholinesterase inhibitory activity. Among various synthesized compounds, 10‐((1‐((3‐(4‐methoxyphenyl)‐1,2,4‐oxadiazol‐5‐yl)methyl)‐1H‐1,2,3‐triazol‐4‐yl)methyl)acridin‐9(10H)‐one 10b showed the most potent anti‐acetylcholinesterase activity (IC50 = 11.55 μm)

  在这项研究中，设计，合成并评估了新的a啶酮1,2,4，恶二唑1,2,3-三唑杂合体的乙酰胆碱酯酶和丁酰胆碱酯酶抑制活性。在各种合成的化合物中，10-（（1-（（3-（4--甲氧基苯基）-1,2,4-恶二唑-5-基）甲基）-1 H -1,2,3-三唑-4-基）甲基）吖啶-9-（10 ħ） -酮10b中显示出最有效的抗乙酰胆碱酯酶活性（IC 50  = 11.55  μ米）是一样有效的利凡斯的明。对接结果也与体外结果高度吻合，证实了化合物10b的双重结合抑制活性。
• [EN] PYRIDIN-4-YLAMINE COMPOUNDS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN<br/>[FR] COMPOSES DE PYRIDIN-4-YLAMINE CONVENANT POUR LE TRAITEMENT DE LA DOULEUR NEUROPATHIQUE
  申请人：MERCK & CO INC

  公开号：WO2005051915A1

  公开（公告）日：2005-06-09

  The present invention is directed to a method of use of triazolo-pyridazine compounds in the treatment of neuropathic pain. The present invention is also directed to the use of triazolo-pyridazine compounds in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorders, and panic, as well as in the treatment of pain, Parkinson’s disease, cognitive dysfunction, epilepsy, circadian rhythm and sleep disorders - such as shift-work induced sleep disorder and jet-lag, drug addiction, drug abuse, drug withdrawal and other diseases. The present invention is also directed to novel triazolo-pyridazine compounds that selectively bind to α2δ-1 subunit of Ca channels.

  本发明涉及一种在治疗神经病性疼痛中使用三唑吡啶化合物的方法。本发明还涉及在治疗精神和情绪障碍，如精神分裂症、焦虑、抑郁、躁郁症和恐慌，以及在治疗疼痛、帕金森病、认知功能障碍、癫痫、昼夜节律和睡眠障碍（如倒班引起的睡眠障碍和时差反应）、药物成瘾、药物滥用、药物戒断和其他疾病中使用三唑吡啶化合物的方法。本发明还涉及选择性结合到Ca通道α2δ-1亚基的新型三唑吡啶化合物。
• 이형고리 화합물 및 이를 포함하는 유기전계발광소자
  申请人：SFC CO., LTD. 에스에프씨 주식회사(120060087061) Corp. No ▼ 135511-0105889BRN ▼134-81-54429

  公开号：KR102191778B1

  公开（公告）日：2020-12-16

  본 발명은 신규한 이형고리 화합물 및 이를 발광물질로 포함하는 유기전계 발광소자에 관한 것으로서, 구체적으로 하기 [화학식 1]로 표시되는 이형고리 화합물 및 이를 포함하는 유기전계발광소자는 구동전압, 발광효율 등의 발광특성에 있어 우수한 효과가 있다. [화학식 1]

  This invention relates to a novel heterocyclic compound and an organic electroluminescent device containing it as a luminescent material. Specifically, the heterocyclic compound represented by the following [Chemical Formula 1] and the organic electroluminescent device containing it exhibit excellent effects in luminescent characteristics such as driving voltage and luminous efficiency. [Chemical Formula 1]
• Oxidative CH Bond Functionalization and Ring Expansion with TMSCHN₂: A Copper(I)-Catalyzed Approach to Dibenzoxepines and Dibenzoazepines
  作者：Tobias Stopka、Leyre Marzo、Mercedes Zurro、Simon Janich、Ernst-Ulrich Würthwein、Constantin G. Daniliuc、José Alemán、Olga García Mancheño

  DOI：10.1002/anie.201411726

  日期：2015.4.20

  research. However, their syntheses are generally rather tedious, requiring several steps that involve a Wagner–Meerwein‐type rearrangement under harsh conditions. Herein, we present the first copper(I)‐catalyzed oxidative CH bond functionalization and ring expansion with TMSCHN2 to yield these important derivatives in a facile and straightforward way.

  三环二苯并x庚因和二苯并ze庚因是制药工业和学术研究的重要治疗剂。但是，它们的合成通常很繁琐，需要几个步骤，包括在恶劣条件下进行Wagner-Meerwein型重排。在此，我们呈现第一铜（I） -催化氧化Ç  H键官能化和扩环与TMSCHN 2以容易和简单的方法，以产生这些重要的衍生物。